BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16337447)

  • 1. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma.
    Pearlman DS; Berger WE; Kerwin E; Laforce C; Kundu S; Banerji D
    J Allergy Clin Immunol; 2005 Dec; 116(6):1206-12. PubMed ID: 16337447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily ciclesonide in children: efficacy and safety in asthma.
    Gelfand EW; Georgitis JW; Noonan M; Ruff ME
    J Pediatr; 2006 Mar; 148(3):377-83. PubMed ID: 16615971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids.
    Berger WE; Kerwin E; Bernstein DI; Pedinoff A; Bensch G; Karafilidis J
    Allergy Asthma Proc; 2009; 30(3):304-14. PubMed ID: 19549432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety evaluation of ciclesonide in mild-to-moderate persistent asthma previously treated with inhaled corticosteroids.
    Meltzer EO; Korenblat PE; Weinstein SF; Noonan M; Karafilidis J
    Allergy Asthma Proc; 2009; 30(3):293-303. PubMed ID: 19549431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of once-daily inhaled ciclesonide in adults with mild to moderate asthma: a double-blind, placebo-controlled study.
    Adachi M; Ishihara K; Inoue H; Kudo K; Takahashi K; Morita Y; Masuda K; Takada Y; Kato R; Miyamoto T
    Respirology; 2007 Jul; 12(4):566-72. PubMed ID: 17587424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma.
    von Berg A; Engelstätter R; Minic P; Sréckovic M; Garcia Garcia ML; Latoś T; Vermeulen JH; Leichtl S; Hellbardt S; Bethke TD
    Pediatr Allergy Immunol; 2007 Aug; 18(5):391-400. PubMed ID: 17617808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
    Bateman ED; Cheung D; Lapa e Silva J; Göhring UM; Schäfer M; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(3):489-98. PubMed ID: 18178494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
    Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up.
    O'Connor BJ; Kilfeather S; Cheung D; Kafé H; Blagden MD; Schlösser N; Ayres JG; Weber HJ; Engelstätter R
    Expert Opin Pharmacother; 2010 Dec; 11(17):2791-803. PubMed ID: 20958119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma.
    Langdon CG; Adler M; Mehra S; Alexander M; Drollmann A
    Respir Med; 2005 Oct; 99(10):1275-85. PubMed ID: 16024244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
    Lipworth BJ; Kaliner MA; LaForce CF; Baker JW; Kaiser HB; Amin D; Kundu S; Williams JE; Engelstaetter R; Banerji DD
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
    Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L
    Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
    Dahl R; Engelstätter R; Trebas-Pietraś E; Kuna P
    Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study.
    Pedersen S; Potter P; Dachev S; Bosheva M; Kaczmarek J; Springer E; Dunkel J; Engelstätter R
    Respir Med; 2010 Nov; 104(11):1618-28. PubMed ID: 20619624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
    Ukena D; Biberger C; Steinijans V; von Behren V; Malek R; Weber HH; Beck E; Linnhoff A
    Pulm Pharmacol Ther; 2007; 20(5):562-70. PubMed ID: 16962345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.